Broad-spectrum cancer drugs are versatile in treating various types of cancer. Therefore, doctors should carefully evaluate the patient's specific cancer subtype and overall condition when selecting and modifying treatment strategies.
Because broad-spectrum anticancer drugs may act on many different physiological processes, side effects can be more complex and varied.
Common side effects include fatigue, rash, gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea), immune-related side effects (e.g., inflammation, endocrine disorders), etc. These side effects need to be monitored and managed regularly.
Individualized dosage adjustments of broad-spectrum anticancer drugs should be based on factors such as the patient's weight, age, liver and kidney function to optimize treatment efficacy.
Resistance to broad-spectrum anticancer drugs may develop during treatment, necessitating regular assessment of treatment outcomes. If resistance is detected, treatment adjustment should be promptly considered.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: